Mast cell and T cell communication; amplification and control of adaptive immunity.
暂无分享,去创建一个
[1] S. Balk,et al. Kinetics of cytolytic T lymphocyte binding to target cells in suspension. , 1981, Journal of immunology.
[2] Yukihiko Kitamura,et al. Decrease of mast cells in w/wv mice and their increase by bone marrow transplantation. , 1978 .
[3] Walid Beghdadi,et al. Mast Cell-Dependent Down-Regulation of Antigen-Specific Immune Responses by Mosquito Bites1 , 2006, The Journal of Immunology.
[4] Y. Naparstek,et al. Constitutive hyperhistaminaemia: a possible mechanism for recurrent anaphylaxis , 2001, Scandinavian journal of clinical and laboratory investigation.
[5] L. Bouton,et al. Stat5 expression is critical for mast cell development and survival. , 2003, Blood.
[6] C. Chen,et al. Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. , 2005, The American journal of pathology.
[7] K. Tasaka,et al. Histamine release from beta-escin-permeabilized rat peritoneal mast cells and its inhibition by intracellular Ca2+ blockers, calmodulin inhibitors and cAMP. , 1989, Immunopharmacology.
[8] K. Melmon,et al. Regulatory effects of mast cells on lymphoid cells: the role of histamine type 1 receptors in the interaction between mast cells, helper T cells and natural suppressor cells. , 1986, Cellular immunology.
[9] H. Abboud,et al. Actions and metabolism of histamine in glomeruli and tubules of the human kidney. , 1984, Kidney international.
[10] K. Ishizaka,et al. Identification of gamma-E-antibodies as a carrier of reaginic activity. , 1967, Journal of immunology.
[11] Tomoko Fujita,et al. Type I Interferons Attenuate T Cell Activating Functions of Human Mast Cells by Decreasing TNF-α Production and OX40 Ligand Expression While Increasing IL-10 Production , 2006, Journal of Clinical Immunology.
[12] J. Johnston,et al. In vitro correction of JAK3-deficient severe combined immunodeficiency by retroviral-mediated gene transduction , 1996, The Journal of experimental medicine.
[13] M. Tsai,et al. Mast cells in the development of adaptive immune responses , 2005, Nature Immunology.
[14] D. Conrad,et al. IL-10 Suppresses Mast Cell IgE Receptor Expression and Signaling In Vitro and In Vivo1 , 2008, The Journal of Immunology.
[15] H. Xiong,et al. SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. , 2008, Blood.
[16] D. Friend,et al. Induction of a selective and persistent extravasation of neutrophils into the peritoneal cavity by tryptase mouse mast cell protease 6. , 1998, Journal of immunology.
[17] S. Balk,et al. Specific reversal of cytolytic T lymphocyte--target cell interaction. , 1981, Journal of supramolecular structure and cellular biochemistry.
[18] Zhao-You Tang,et al. Combination of peritumoral mast cells and T‐regulatory cells predicts prognosis of hepatocellular carcinoma , 2009, Cancer science.
[19] K. Okumura,et al. Notch signaling confers antigen-presenting cell functions on mast cells. , 2009, The Journal of allergy and clinical immunology.
[20] J. Rivera. Snake bites and bee stings: the mast cell strikes back , 2006, Nature Medicine.
[21] G. B. West,et al. Tissue mast cells: studies with a histamine-liberator of low toxicity (compound 48/80). , 1955, The Journal of pathology and bacteriology.
[22] P. Wolters,et al. Tissue‐selective mast cell reconstitution and differential lung gene expression in mast cell‐deficient KitW‐sh/KitW‐sh sash mice , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[23] N. Novak,et al. Histamine and histamine intolerance. , 2007, The American journal of clinical nutrition.
[24] S. Thakurdas,et al. The Mast Cell-restricted Tryptase mMCP-6 Has a Critical Immunoprotective Role in Bacterial Infections* , 2007, Journal of Biological Chemistry.
[25] J. Lohr,et al. Regulatory T cells in the periphery , 2006, Immunological reviews.
[26] Jingyong Zhao,et al. Adoptive Transfer of In Vitro-Stimulated CD4+CD25+ Regulatory T Cells Increases Bacterial Clearance and Improves Survival in Polymicrobial Sepsis , 2005, The Journal of Immunology.
[27] Baowei Su,et al. Cimetidine enhances immune response of HBV DNA vaccination via impairment of the regulatory function of regulatory T cells. , 2008, Biochemical and biophysical research communications.
[28] Stephen J Galli,et al. Mast cell–derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B , 2007, Nature Immunology.
[29] C. Gutekunst,et al. Mast Cells Are Essential for Early Onset and Severe Disease in a Murine Model of Multiple Sclerosis , 2000, The Journal of experimental medicine.
[30] D. Metcalfe,et al. Induction and enhancement of Fc(epsilon)RI-dependent mast cell degranulation following coculture with activated T cells: dependency on ICAM-1- and leukocyte function-associated antigen (LFA)-1-mediated heterotypic aggregation. , 1998, Journal of immunology.
[31] C. Chen,et al. Mast Cells Can Enhance Resistance to Snake and Honeybee Venoms , 2006, Science.
[32] J. Marshall. Mast-cell responses to pathogens , 2004, Nature Reviews Immunology.
[33] J. White,et al. Activation of basophils and mast cells for mediator release. , 1987, International archives of allergy and applied immunology.
[34] D. Payan,et al. R406, an Orally Available Spleen Tyrosine Kinase Inhibitor Blocks Fc Receptor Signaling and Reduces Immune Complex-Mediated Inflammation , 2006, Journal of Pharmacology and Experimental Therapeutics.
[35] M. Tsai,et al. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. , 2005, Annual review of immunology.
[36] P. Fietta. Life-or-death fate in the adaptive immune system. , 2007, Rivista di biologia.
[37] D. Metcalfe,et al. Mast cells in innate immunity , 2000, Immunological reviews.
[38] C. Benoist,et al. Genetic inversion in mast cell-deficient (Wsh) mice interrupts corin and manifests as hematopoietic and cardiac aberrancy. , 2008, The American journal of pathology.
[39] R. Noelle,et al. Mast Cell Degranulation Breaks Peripheral Tolerance , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[40] E. Masuda,et al. Immunotoxicity assessment for the novel Spleen tyrosine kinase inhibitor R406. , 2007, Toxicology and applied pharmacology.
[41] Carlos D Ramirez,et al. TGFβ1 induces mast cell apoptosis , 2006 .
[42] M. Tsai,et al. Mast Cells Enhance T Cell Activation: Importance of Mast Cell Costimulatory Molecules and Secreted TNF1 , 2006, The Journal of Immunology.
[43] P. Conlon,et al. IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide. , 1994, Journal of immunology.
[44] M. Colombo,et al. CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. , 2008, Immunity.
[45] S. Jewell,et al. Rat peritoneal mast cells present antigen to a PPD-specific T cell line. , 1994, Cellular immunology.
[46] R. Siegel,et al. Rheumatologic and autoimmune manifestations of primary immunodeficiency disorders , 2009, Current opinion in rheumatology.
[47] W. Paul,et al. Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores , 1989, Nature.
[48] M. Beaven. Our perception of the mast cell from Paul Ehrlich to now , 2009, European journal of immunology.
[49] C. Tkaczyk,et al. Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes , 1996, European journal of immunology.
[50] T. Strom,et al. T-regulatory cells shift from a protective anti-inflammatory to a cancer-promoting proinflammatory phenotype in polyposis. , 2009, Cancer research.
[51] K. Austen,et al. Mast cell mediator release as a function of cyclic AMP-dependent protein kinase activation , 1981, The Journal of experimental medicine.
[52] David C. Gondek,et al. Mast cells are essential intermediaries in regulatory T-cell tolerance , 2006, Nature.
[53] S. Abraham,et al. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α , 1996, Nature.
[54] E. Kölsch. The genetic control of T cell‐mediated immunity against the DBA/2 mastocytoma P‐815. II. Low responsiveness in T cell‐mediated cytotoxicity accompanied by the inability to produce antibodies in a secondary response , 1975, European journal of immunology.
[55] Melissa A Brown,et al. Mast Cells , 2008, Annals of the New York Academy of Sciences.
[56] D. Hoskin,et al. Mast Cells Down-Regulate CD4+CD25+ T Regulatory Cell Suppressor Function via Histamine H1 Receptor Interaction1 , 2009, The Journal of Immunology.
[57] C. Gutekunst,et al. Mast Cells Exert Effects Outside the Central Nervous System to Influence Experimental Allergic Encephalomyelitis Disease Course 1 , 2003, The Journal of Immunology.
[58] Lin Zhao,et al. Induction of Adaptive T Regulatory Cells That Suppress the Allergic Response by Coimmunization of DNA and Protein Vaccines1 , 2008, The Journal of Immunology.
[59] Y. Okayama,et al. T Cell Proliferation by Direct Cross-Talk between OX40 Ligand on Human Mast Cells and OX40 on Human T Cells: Comparison of Gene Expression Profiles between Human Tonsillar and Lung-Cultured Mast Cells1 , 2004, The Journal of Immunology.
[60] M. Colombo,et al. Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation. , 2009, Blood.
[61] R. Liblau,et al. Cell-cell cooperation at the T helper cell/mast cell immunological synapse. , 2009, Blood.
[62] W. Leonard,et al. Cutting Edge: CD4 T Cell-Mast Cell Interactions Alter IgE Receptor Expression and Signaling1 , 2008, The Journal of Immunology.
[63] R. Noelle,et al. Mast cells as regulators of adaptive immunity to tumours , 2009, Clinical and experimental immunology.
[64] J S Gonnella,et al. What have we learned, and where do we go from here? , 1993, Academic medicine : journal of the Association of American Medical Colleges.
[65] Melissa A Brown,et al. Mast cells as modulators of T‐cell responses , 2007, Immunological reviews.
[66] J. Kinet,et al. Emerging picture of the receptor with high affinity for IgE. , 1989, International archives of allergy and applied immunology.
[67] Christoph Wilhelm,et al. Transforming growth factor-β 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9–producing subset , 2008, Nature Immunology.
[68] V. Secor,et al. Mast cells are required for optimal autoreactive T cell responses in a murine model of multiple sclerosis , 2005, European journal of immunology.
[69] Yuetsu Tanaka,et al. Expression and function of OX40 ligand on human dendritic cells. , 1997, Journal of immunology.
[70] R. Paus,et al. Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions. , 2009, Immunity.
[71] M. Tsai,et al. Mast cells enhance T cell activation: Importance of mast cell-derived TNF. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[72] R. Weissleder,et al. Mast cells are an essential hematopoietic component for polyp development , 2007, Proceedings of the National Academy of Sciences.
[73] S. Holgate,et al. Role of adenylate cyclase in immunologic release of mediators from rat mast cells: agonist and antagonist effects of purine- and ribose-modified adenosine analogs. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[74] P. Askenase. Immune inflammatory responses to parasites: the role of basophils, mast cells and vasoactive amines. , 1977, The American journal of tropical medicine and hygiene.
[75] P. Askenase,et al. The effect of histamine, antihistamines, and a mast cell stabilizer on the growth of cloudman melanoma cells in DBA/2 mice. , 1983, The Journal of investigative dermatology.
[76] F. Noonan,et al. Dermal Mast Cells Determine Susceptibility to Ultraviolet B–induced Systemic Suppression of Contact Hypersensitivity Responses in Mice , 1998, The Journal of experimental medicine.
[77] S. Galli,et al. Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines , 1989, The Journal of experimental medicine.
[78] J. Morrow,et al. Evidence that histamine is the causative toxin of scombroid-fish poisoning. , 1991, The New England journal of medicine.
[79] J. Drazen,et al. Evaluation of the Substrate Specificity of Human Mast Cell Tryptase βI and Demonstration of Its Importance in Bacterial Infections of the Lung* , 2001, The Journal of Biological Chemistry.
[80] R. Pawankar,et al. Heterogeneity of mast cells and T cells in the nasal mucosa. , 1996, The Journal of allergy and clinical immunology.
[81] J. Kinet,et al. Complete structure and expression in transfected cells of high affinity IgE receptor , 1989, Nature.
[82] John T. Chang,et al. Inducible MHC Class II Expression by Mast Cells Supports Effector and Regulatory T Cell Activation 1 , 2009, The Journal of Immunology.
[83] Y. Okayama,et al. Identification of specific gene expression profiles in human mast cells mediated by Toll-like receptor 4 and FcepsilonRI. , 2003, Blood.
[84] E. Orr. Presence and Distribution of Nervous System‐Associated Mast Cells That May Modulate Experimental Autoimmune Encephalomyelitis , 1988 .